Viewing Study NCT00903292


Ignite Creation Date: 2025-12-24 @ 3:48 PM
Ignite Modification Date: 2025-12-28 @ 1:30 AM
Study NCT ID: NCT00903292
Status: UNKNOWN
Last Update Posted: 2009-05-18
First Post: 2009-05-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Tailored Second Line Treatment by Epidermal Growth Factor Receptor (EGFR) Mutation in Patients With Advanced Lung Adenocarcinoma
Sponsor: National Cheng-Kung University Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module